Design Therapeutics, Inc. (NASDAQ:DSGN) Shares Purchased by Wells Fargo & Company MN
Wells Fargo & Company MN boosted its position in Design Therapeutics, Inc. (NASDAQ:DSGN – Free Report) by 27.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,428 shares of the company’s stock after buying an additional 4,013 shares during the quarter. […]
